Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | TP53 | P04637 | 3/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9885396 | 0.87 | TSHR (0.39) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL336819 | 0.85 | TSHR (0.33) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL268448 | 0.83 | TSHR (0.33) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL15356238 | 0.82 | TSHR (0.33) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL5827874 | 0.82 | GSTP1 (0.31) | — | |
| SCHEMBL15356230 | 0.81 | TSHR (0.30) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL24288116 | 0.79 | CHRM1 (0.31) | TSHR | |
| SCHEMBL19881818 | 0.79 | TSHR (0.33) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL13951036 | 0.79 | TSHR (0.33) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL14113901 | 0.79 | TSHR (0.37) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371580-B2 | Radiation curable inkjet inks | AGFA NV (BE) | 2025-07-29 | — | — | US | claimed |
| EP-4263731-B1 | UV CURABLE INKJET INKS AND INKJET PRINTING METHODS | AGFA NV (BE) | 2024-09-18 | — | — | EP | claimed |
| US-20240117207-A1 | UV Curable Inkjet Inks and Inkjet Printing Methods | AGFA NV (BE) | 2024-04-11 | — | — | US | claimed |
| CN-113677718-B | Radiation curable compositions for rapid prototyping or rapid manufacturing processes | 古莎有限公司 | 2023-12-01 | — | — | CN | claimed |
| EP-4263731-A1 | UV CURABLE INKJET INKS AND INKJET PRINTING METHODS | AGFA NV (BE) | 2023-10-25 | — | — | EP | claimed |
| EP-3833719-B1 | DECORATED LEATHER MANUFACTURING | AGFA NV (BE) | 2023-01-04 | — | — | EP | claimed |
| WO-2022128258-A1 | UV CURABLE INKJET INKS AND INKJET PRINTING METHODS | AGFA NV (BE) | 2022-06-23 | — | — | WO | claimed |
| US-20210332255-A1 | RADIATION CURABLE INKJET INKS | AGFA NV (BE) | 2021-10-28 | — | — | US | claimed |
| EP-3608373-B1 | RADIATION CURABLE INKJET INKS | AGFA NV (BE) | 2021-10-06 | — | — | EP | claimed |
| US-20210292859-A1 | DECORATED LEATHER MANUFACTURING | AGFA NV (BE) | 2021-09-23 | — | — | US | claimed |
| EP-3833719-A1 | DECORATED LEATHER MANUFACTURING | AGFA NV (BE) | 2021-06-16 | — | — | EP | claimed |
| WO-2020030664-A1 | RADIATION CURABLE INKJET INKS | AGFA NV (BE) | 2020-02-13 | — | — | WO | claimed |
| WO-2020030679-A1 | DECORATED LEATHER MANUFACTURING | AGFA NV (BE) | 2020-02-13 | — | — | WO | claimed |
| EP-3608373-A1 | RADIATION CURABLE INKJET INKS | AGFA NV (BE) | 2020-02-12 | — | — | EP | claimed |
| US-7067584-B2 | Solvent-containing coating material and the use thereof | BASF COATINGS AG (DE) | 2006-06-27 | — | — | US | claimed |
| US-20040019142-A1 | Solvent-containing coating material and the use thereof | RINK HEINZ-PETER (DE) | 2004-01-29 | — | — | US | claimed |
| US-20260085203-A1 | Pigmented Free Radical Curable Inkjet Inks | AGFA NV (BE) | 2026-03-26 | — | — | US | disclosed |
| EP-4688887-A1 | FORMULATIONS USABLE IN ADDITIVE MANUFACTURING OF 3D OBJECTS THAT FEATURE AN ELASTOMERIC MATERIAL | Stratasys Ltd. (IL) | 2026-02-11 | — | — | EP | disclosed |
| US-20030143414-A1 | Aqueous primary dispersions and coating agents, methods for producing them and their use | BENDIX MAXIMILIAN (DE) | 2003-07-31 | — | — | US | disclosed |
| US-20030100673-A1 | Aqueous primary dispersions, method for preparation and use thereof | BASF COATINGS AKTIENGESELLSCHAFT (DE) | 2003-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085203-A1 | Pigmented Free Radical Curable Inkjet Inks | LIG4, DCLRE1A, LIG1 | TSHR 4721/4885ALDH1A1 48/4885TP53 1095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.